DL-Buthionine-(S,R)-sulfoximine hydrochloride

SKU:BHB21900151
Research Validated
Overview
Click light‑blue chips for details
DL-Buthionine-(S,R)-sulfoximine hydrochloride is an inhibitor supplied as a solid. Relevant to Apoptosis research. Molecular formula C8H19ClN2O3S, molecular weight 258.77 g/mol. Also known as Buthionine sulfoximine hydrochloride and BSO hydrochloride.
Purity 99.09%
Molecular Weight 258.77 g/mol
Form Solid
Storage -20°C as supplied; in solvent -80°C
Options selector
Catalog no. Size
HY-106376B-25MG 25 mg
HY-106376B-50MG 50 mg
HY-106376B-100MG 100 mg
HY-106376B-250MG 250 mg
HY-106376B-500MG 500 mg
HY-106376B-1G 1 g
HY-106376B-5G 5 g
HY-106376B-1MLX10MMWATER 1 mL x 10 mM (in Water)
Available Options

Select the variant that best fits your experiment. Availability and lead time may vary by option.

  • Options: Size: 25 mg, 50 mg, 100 mg, 250 mg, 500 mg, 1 g, 5 g, 1 mL x 10 mM (in Water)
  • Lead time: varies by selected option.
  • Storage: -20°C, sealed storage, away from moisture and light. In solvent: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light).
  • Shipping: Room temperature in continental US; may vary elsewhere.
  • Upon receipt: transfer to -20°C as soon as possible.
Field Specification
Alternative names Buthionine sulfoximine hydrochloride; BSO hydrochloride
Applications
  • Functional Assay (In Vitro)
Molecular weight 258.77
Molecular formula C8H19ClN2O3S
Purity 99.09%
SMILES OC(C(N)CCS(CCCC)(=N)=O)=O.[H]Cl
Form Solid
Storage -20°C, sealed storage, away from moisture and light. In solvent: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light).
Shipping Room temperature in continental US; may vary elsewhere.
Catalog no. (Mfr.) HY-106376B
Main SKU BHB21900151
Inhibitors

Compound Overview

DL-Buthionine-(S,R)-sulfoximine hydrochloride, also known as Buthionine sulfoximine hydrochloride and BSO hydrochloride, is a potent inhibitor of glutamylcysteine synthetase biosynthesis. It is supplied as a white to off-white solid (C8H19ClN2O3S, MW 258.77) at 99.09% purity.

Physical & Chemical Properties

Molecular Formula C8H19ClN2O3S
Molecular Weight 258.77 g/mol
Purity 99.09%
Appearance Solid
Color White to off-white
SMILES OC(C(N)CCS(CCCC)(=N)=O)=O.[H]Cl
Signaling Pathway Apoptosis
Solubility In Vitro: H2O: 100 mg/mL (386.44 mM; Requires sonication) DMSO: < 1 mg/mL (insoluble or slightly soluble)
Storage -20°C, sealed storage, away from moisture and light. In solvent: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light).
Shipping Room temperature in continental US; may vary elsewhere.

Literature Cited

Sources cited in this description and in the In Vitro & In Vivo Data tab. Peer-reviewed publications that used this product are listed under References.

[1]. Griffith OW, et al. Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine). J Biol Chem. 1979 Aug 25;254(16):7558-60.

[2]. Vanhoefer U, et al. d,l-buthionine-(S,R)-sulfoximine potentiates in vivo the therapeutic efficacy of doxorubicin against multidrug resistance protein-expressing tumors. Clin Cancer Res. 1996 Dec;2(12):1961-8.

Safety

For Research Use Only. Not for use in diagnostic or therapeutic procedures, and not for human or veterinary use. Handle in accordance with the Safety Data Sheet and your institution's chemical hygiene plan.

In Vitro

SolventSolubilityNotes
H2O100 mg/mL (386.44 mM)requires sonication
DMSO< 1 mg/mLinsoluble or slightly soluble

Aliquot the stock solution and store it at -80°C (up to 6 months) or -20°C (up to 1 month); sealed storage, away from moisture and light; avoid repeated freeze-thaw cycles.

If water is used as the stock solvent, dilute to the working solution and sterilize it through a 0.22 μm filter before use.

In Vivo

Choose the formulation that suits the animal model and route of administration. Percentages are volume ratios of the final working solution. Prepare the working solution fresh on the day of dosing; if precipitation or phase separation occurs, gentle warming or sonication can help.

Direct preparation of the working solution

These formulations are prepared directly, without a DMSO stock; use them promptly after preparation.

Protocol 1

CompositionPBS
Result100 mg/mL (386.44 mM); clear solution; requires sonication

Data provided by the manufacturer.

In Vitro

Buthionine sulfoximine, an analog of methionine sulfoximine, inhibits gamma-glutamylcysteine synthetase roughly 20 times more effectively than does prothionine sulfoximine, and it is at least 100 times more effective than methionine sulfoximine[1].

In Vivo

In mice bearing HT1080 and HT1080/DR4 xenografts, nontoxic doses of D,L-Buthionine-(S,R)-sulfoximine (300 and 600 mg/kg/day), given as a continuous i.v infusion, lower GSH plasma levels by 60% and GSH tumor levels by more than 95 %, in both parental and multidrug-resistant tumors[2].

Data provided by the manufacturer. Numbered citations refer to the Literature Cited list in the product description.

Q.Why is there no price on some sizes?
A.Availability and lead time for those sizes are confirmed on inquiry. Send us the size you need and we will come back with price and lead time.
Q.Can this be used in humans or for diagnostics?
A.No. This product is supplied For Research Use Only. It is not for diagnostic or therapeutic procedures and not for human or veterinary use.

Need this compound in a format that drops straight into your assay? We can tailor formulation, chemistry, and documentation so your results stay consistent across runs and re-orders.

  • Format options: solid or pre-dissolved solution (choose solvent), target concentration, aliquots, light/moisture-protected packaging
  • Chemistry options: free base/acid vs salt forms, hydrate/solvate preference, stereoisomer control (single enantiomer or racemate), close analogs
  • Add-on labels & handles: D/¹³C/¹⁵N isotopes (LC-MS/internal standards), azide/alkyne or other functional handles for conjugation
  • QC & documentation: standard COA or enhanced analytical pack (HPLC/LC-MS/NMR), chiral purity, residual solvents, water content (KF), method-specific specs
  • Scale & continuity: mg to gram scale, bulk pricing, lot reservation, repeat-order continuity

To quote quickly, tell us: compound name + CAS/structure (SMILES or mol file), intended assay context, solvent preference, salt/stereochemistry requirements, purity/QC level, and the amount (mg–g).

Can’t find the compound you’re looking for?
Send the CAS or structure and your specs. We can help source it, suggest close equivalents, or discuss custom synthesis with the right QC documentation (RUO).

Catabolism of extracellular glutathione supplies cysteine to support tumours. Nature 2026 May;653(8115):933-941. PMID: 41851454

The Acetyltransferase ARD1 Induces Glutathione Synthesis to Facilitate Ferroptosis Evasion in Hepatocellular Carcinoma. Cancer Res 2025 Aug 21. PMID: 40838989

Catalytic Proximal Protein Oligomerization as an Anti-Tumor Strategy Targeting WDR5. Nat Commun 2026 Mar 13;17(1):3879. PMID: 41820364

SLC13A3 is a major effector downstream of activated β-catenin in liver cancer pathogenesis. Nat Commun 2024 Aug 30;15(1):7522. PMID: 39215042

Suppression of the LKB1-AMPK-SLC7A11-GSH signaling pathway sensitizes NSCLC to albumin-bound paclitaxel via oxidative stress. Redox Biol 2025 Apr:81:103567. PMID: 40023979

NRF2 preserves genomic integrity by facilitating ATR activation and G2 cell cycle arrest. Nucleic Acids Res 2020 Sep 18;48(16):9109-9123. PMID: 32729622

Donafenib and GSK-J4 Synergistically Induce Ferroptosis in Liver Cancer by Upregulating HMOX1 Expression. Adv Sci (Weinh) 2023 Aug;10(22):e2206798. PMID: 37330650

Direct recruitment of TONSOKU by the N-terminal tails of histone variants H2A.X and H2A.W coordinates DNA repair. Sci Adv 2025 Dec 19;11(51):eady2104. PMID: 41406205

Liver regeneration-associated hepatocellular YAP1 activation prevents colorectal cancer liver metastasis through glutamine competition. Sci Adv 2025 Aug 22;11(34):eadw6926. PMID: 40845109

Targeting polyamine metabolism induces oxidative/carbonyl stress to reinvigorate antitumor immunity in prostate cancer. J Control Release 2025 Sep 30;388(Pt 1):114283. PMID: 41038348

Get a Quote

Please use this form for bulk quantity requests or customized products.

Contact Information

Product Information

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today